CUVPOSA (Glycopyrrolate) drug information from MPR
Links shared publicly online about this topic.
- 129total visits
CUVPOSA (Glycopyrrolate) drug information from MPR
empr.com —
CUVPOSA (Glycopyrrolate) drug information for Drooling from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.
View full resource at empr.com
Most Recently Shared on July 22, 2011 at 4:29 am By:
Cuvposa approved for chronic severe drooling associated with neurologic conditions - MPR
empr.com — “The FDA has approved Cuvposa (glycopyrrolate liquid, from Shionogi), an orphan drug, for the treatment of chronic severe drooling associated with neurologic conditions (eg, cerebral palsy) in patients 3"16 years of age.” View full resource at empr.com
Most Recently Shared on July 29, 2010 at 4:02 pm By:
MPR News: Cuvposa approved for chronic severe drooling associated with neurologic conditions: The FDA has approved... http://bit.ly/ar1eRe
Advertisement
